Steven M. Silverman

Statistics

Publications

Citations

2.3K

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Stanford University

Scripps Research Institute

Codexis (United States)

Simon Fraser University

Steven M. Silverman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacy, and drug discovery.

ORCID

Publications per year

2004–2024

Publications

Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry

Matthew Whiting, John Muldoon, Ying‐Chuan Lin et al. · Angewandte Chemie International Edition · 2006 · 510 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +9

Enantioselective Construction of Spirocyclic Oxindolic Cyclopentanes by Palladium-Catalyzed Trimethylenemethane-[3+2]-Cycloaddition

Barry M. Trost, Nicolai Cramer, Steven M. Silverman · Journal of the American Chemical Society · 2007 · 417 citations · Full text

Natural Sciences, Chemistry, Catalysis +8

Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19

John A. McIntosh, Tamas Benkovics, Steven M. Silverman et al. · ACS Central Science · 2021 · 192 citations · Full text

Life Sciences, Biotechnology, Medicinal Chemistry +14

Palladium-Catalyzed Asymmetric [3 + 2] Trimethylenemethane Cycloaddition Reactions

Barry M. Trost, James P. Stambuli, Steven M. Silverman et al. · Journal of the American Chemical Society · 2006 · 132 citations · Full text

Natural Sciences, Chemistry, Catalysis +10

Palladium-Catalyzed Asymmetric [3+2] Cycloaddition of Trimethylenemethane with Imines

Barry M. Trost, Steven M. Silverman, James P. Stambuli · Journal of the American Chemical Society · 2007 · 118 citations · Full text

Natural Sciences, Chemistry, Catalysis +14

1–5 of 21